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re-challenge
Jean-Rémy Sadeyen1, Pete Kaiser2, Mark P Stevens2 and Francis Dziva1,3*Abstract
Avian pathogenic Escherichia coli (APEC) cause severe respiratory and systemic disease in poultry yet the nature and
consequences of host immune responses to infection are poorly understood. Here, we describe a turkey sub-acute
respiratory challenge model and cytokine, cell-mediated and humoral responses associated with protection against
homologous re-challenge. Intra-airsac inoculation of turkeys with 105 colony-forming units of APEC O78:H9 strain
χ7122nalR induced transient and mild clinical signs of colibacillosis followed by clearance of the bacteria from the
lungs and visceral organs. Upon re-challenge with 107 χ7122nalR, primed birds were solidly protected against clinical
signs and exhibited negligible bacterial loads in visceral organs, whereas age-matched control birds exhibited high
lesion scores and bacterial loads in the organs. Levels of mRNA for signature cytokines suggested induction of a
Th1 response in the lung, whereas a distinct anti-inflammatory cytokine profile was detected in the liver.
Proliferative responses of splenocytes to either Concanavalin A or soluble χ7122nalR antigens were negligible prior to
clearance of bacteria, but APEC-specific responses were significantly elevated at later time intervals and at re-challenge
relative to control birds. Primary infection also induced significantly elevated χ7122nalR-specific serum IgY and bile IgA
responses which were bactericidal against χ7122nalR and an isogenic Δrfb mutant. Bactericidal activity was observed in
the presence of immune, but not heat-inactivated immune serum, indicating that the antibodies can fix complement
and are not directed solely at the lipopolysaccharide O-antigen. Such data inform the rational design of strategies to
control a recalcitrant endemic disease of poultry.Introduction
Avian pathogenic Escherichia coli (APEC) are a leading
cause of morbidity and mortality in poultry and exert
significant economic and welfare costs. Infections are fre-
quently associated with sudden death, salpingitis, periton-
itis, pericarditis, perihepatitis, airsacculitis and with reduced
yield, quality and hatching of eggs. Analysis of the reper-
toire of virulence-associated genes among APEC has in-
dicated that some strains are closely related to E. coli
causing human extraintestinal infections, in particular
uropathogenic E. coli and neonatal meningitis-causing* Correspondence: francis.dziva@sta.uwi.edu
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reproduction in any medium, provided the orE. coli, indicating that they may also pose a threat of
zoonosis [1,2]. Serogroups O1, O2 and O78 are com-
monly associated with avian colibacillosis; however, many
other serogroups have been isolated from diseased birds
and the prevalence varies with geographical location
reviewed in [3,4]. Respiratory viral or Mycoplasma infec-
tions, the onset of sexual maturity and stress associated
with sub-optimal husbandry practices are leading anteced-
ents to colibacillosis in farmed poultry. Despite improve-
ments in poultry production systems over the years, APEC
continue to pose a formidable challenge to poultry farmers,
threatening food security at a time of increasing global de-
mand. The expansion of free-range production systems in
Europe and elsewhere may be expected to increase the in-
cidence of colibacillosis owing to greater exposure of
farmed birds to environmental pathogens, stress and injuryl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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field surveys colibacillosis was the most common bacterial
infection in birds reared free-range (with cases peaking
between onset of lay and 30 weeks of age) and a positive
correlation between vent-pecking and the incidence of
colibacillosis was reported [5,6].
Systemic APEC infections are believed to arise from
colonisation of the lower respiratory tract following in-
halation of contaminated faecal dust, where levels can
reach up to 106 viable E. coli per gram in poultry houses
[7]. Colonisation of the airsacs is enhanced by suppres-
sion of muco-ciliary activity and other upper respiratory
tract defences resulting from concurrent infections and
elevated ammonia levels in poultry houses. Avian airsacs
are relatively avascular structures lacking effective resident
defence mechanisms [8], hence control of pathogens is
thought to be reliant upon recruitment of heterophils and
macrophages [9]. The mode of translocation of APEC
from the respiratory tract to the bloodstream is ill-defined.
APEC can be found in the bloodstream as early as 3 hours
after intra-airsac inoculation of naïve birds [10,11], and
the immune responses that constrain such spread are un-
clear. Systemic spread of APEC may be followed by sepsis
or localised inflammation in survivors involving extensive
heterophil infiltration in organs of the reticulo-endothelial
system [12-14].
Prophylactic use of antibiotics to control APEC in poultry
is restricted owing to the risk of residues entering the food
chain and the potential for the evolution of multi-drug re-
sistant strains. Vaccination offers an attractive route to
control APEC and inactivated and live-attenuated vaccines
are commercially available. Autologous bacterins are ef-
fective but confer serogroup-specific protection and are
believed to act principally through induction of humoral
responses. The serogroup-specificity of such vaccines has
been inferred to be due to the dominance of responses to
the lipopolysaccharide O antigen. As avian colibacillosis is
caused by multiple APEC serotypes, a requirement exists
for broadly cross-protective vaccines. Earlier studies indi-
cate that live-attenuated APEC vaccines or a low dose of
virulent APEC confer a higher degree of cross-serogroup
protection compared to killed vaccines [15,16], however,
the immunological basis of protection has not been prop-
erly dissected. Although passively-administered hyperimmune
serum conferred protection in intact birds [15,17,18], the
contribution of innate defenses and cell-mediated immun-
ity to the control of APEC in the avian host remains
ill-defined. A better understanding of the nature and con-
sequences of avian responses to APEC infection, and their
association with recovery from primary infection and pro-
tection against re-challenge, can be expected to inform
the rational design of control strategies.
In this study, we developed a model of sub-acute
APEC O78:H9 infection in turkey poults and examinedcytokine and antigen-specific cell-mediated and humoral
responses prior to and after homologous re-challenge.
Materials and methods
Bacterial strains, media and growth conditions
APEC strain χ7122nalR was obtained from Professor John
Fairbrother (University of Montreal, Quebec, Canada) and
belongs to serotype O78:H9. Strain χ7122 was originally
isolated from the liver of a turkey with fatal colibacillo-
sis [19]. Strain χ7122nalR is a spontaneous nalidixic acid-
resistant derivative of the original strain [20], which has
been fully sequenced and used in studies on the molecular
basis of virulence of APEC in turkeys [21]. Strain χ7145nalR
is an isogenic Δrfb derivative of χ7122nalR lacking the
lipopolysaccharide O antigen [20]. The strains were stored
in Luria-Bertani (LB) broth containing 15% (v/v) glycerol
at −80 °C. For preparation of inocula, an overnight LB
broth culture of strain χ7122nalR was harvested by centri-
fugation, washed three times in sterile physiological saline
and re-suspended to a volume equating to ca. 106 colony-
forming units (CFU) per mL for primary challenge or ca.
108 CFU/mL for re-challenge. Bacteria were enumerated
by retrospective plating of serial ten-fold dilutions of inoc-
ula or tissue homogenates using MacConkey agar (Oxoid,
Basingstoke, UK) supplemented with 25 μg/mL of nali-
dixic acid (Mac +Nal). If required, prior enrichment was
performed in brain heart infusion (BHI) broth overnight
at 37 °C.
Experimental animals
Animal experiments were conducted according to the re-
quirements of the Animal (Scientific Procedures) Act
1986 (licence no. 30/2463) with the approval of the Local
Ethical Review Committee. Ninety male Big5FLX turkeys
were obtained from Aviagen Ltd. (Tattenhall, Cheshire,
UK) as day-old poults. The poults were housed in biose-
cure accommodation to specific pathogen-free status on
floor litter according to the guidelines issued by Aviagen
Ltd. to simulate commercial practice. Water and a stand-
ard turkey feed ration were provided ad libitum for the
duration of the experiment.
Primary and secondary infection with APEC strain
χ7122nalR
At two weeks of age, birds were divided into two groups
(45 birds each) and housed separately. The first group
was inoculated with 105 CFU of washed stationary phase
χ7122nalR in 100 μL of saline by injection into the left
caudal thoracic airsac and the second control group re-
ceived 100 μL of sterile saline at the same site. Birds
were closely monitored (at least every 3 h) for signs of
disease for 3 days post-infection (dpi) and thereafter
twice daily for the duration of the experiment. On days
1, 3, 5, 7, 14, 21 and 28 after primary infection, five birds
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manely and subjected to post-mortem analysis. From
each bird, pieces of liver and lung were collected in
RNAlater (Ambion, Warrington, UK) for cytokine ana-
lysis, and the remainder was saved for enumerating bac-
teria. The spleen was collected into ice-cold RPMI1640
medium for T cell re-stimulation assays and blood and
bile were collected for serology.
On day 41 post-primary challenge, all the remaining
birds (10 in each group) were inoculated into the right
caudal thoracic airsac with 107 CFU of strain χ7122nalR
in 100 μL of saline and monitored overnight for clinical
signs. After 24 h, all the birds were killed humanely and
subjected to post-mortem analysis. The appearance of le-
sions defining acute colibacillosis (airsacculitis, perihepati-
tis, pericarditis and fibrin deposits on serosal surfaces) was
recorded. Part of the spleen was collected for T cell prolif-
eration assays. Lung, liver, kidney and the remaining
spleen tissue were sampled to enumerate bacteria and
blood and bile were collected for serology.
Enumeration of viable APEC strain χ7122nalR in tissues
Viable tissue-associated bacteria were enumerated essen-
tially as described [21]. Briefly, 1 g of tissue was weighed
and mixed with 9 mL of sterile phosphate-buffered saline
(PBS) and suspended with an UltraTurrax homogenizer
(IKA®Werke, Staufen, Germany) at room temperature to
obtain a 1:10 dilution. Serial 10-fold dilutions were pre-
pared in PBS and plated in triplicate on Mac +Nal agar
and incubated at 37 °C overnight. The theoretical lower
limit of detection by this method was 2 log10 CFU per
gram. Enrichment cultures were also performed in which
1 mL of tissue homogenate was cultured in 9 mL BHI
broth, to give a theoretical lower limit of detection of 1
log10 CFU per gram. Selected nalidixic acid resistant col-
onies were analysed by multiplex polymerase chain reac-
tion (PCR) for virulence-associated genes of APEC (cvaC,
iss, iucD and tsh) using oligonucleotide primers listed in
Table 1 and by slide agglutination with O78-specific anti-
serum (Veterinary Laboratories Agency, Weybridge, UK)
to confirm re-isolation of the challenge strain.
Total RNA extraction and real-time quantitative RT-PCR
for cytokine mRNA
Approximately 15 mg of lung and liver sampled at the
time intervals indicated above were separately homogenized
in 600 μL of RLT lysis buffer (Qiagen, Crawley, UK) using a
bead mill (Retsch MM300, Retsch, Haan, Germany) and
Qiashredders (Qiagen). Total RNA was extracted from ho-
mogenates using an RNeasy mini kit (Qiagen) following
the manufacturer’s instructions. Purified RNA was eluted
with RNase-free water and stored at −20 °C prior to use.
TaqMan real-time quantitative reverse transcriptase
polymerase chain reaction (qRT-PCR) was used to quantifymRNA levels of a proinflammatory cytokine (IL-1β), a
proinflammatory chemokine (CXCLi2), a Th1 signa-
ture cytokine (interferon (IFN)-γ), a Th2 signature cytokine
(interleukin (IL)-13) and two T regulatory cytokines (IL-10
and TGF-β4), with 28S rRNA as a housekeeping gene,
essentially as described [26,27]. Primers and probes spe-
cific for turkey mRNAs are given in Table 1. Briefly, qRT-
PCR was performed using the Master Mix RT-PCR kit
(Eurogentec, Seraing, Belgium). Amplification and detec-
tion of specific products were performed using the
Applied Biosystems 7500 Fast Real-Time PCR System
with the following cycle profile: one cycle at 48 °C for
30 min and 95 °C for 20 s, followed by 40 cycles at 95 °C
for 3 s and 60 °C for 30 s. Quantification was based on
increased fluorescence detected due to hydrolysis of the
target-specific probes by the 5′exonuclease activity of the
rTth DNA polymerase during PCR amplification. The pas-
sive reference dye 6-carboxy-c-rhodamine, not involved in
amplification, was used for normalisation of the reporter
signal. Data are expressed in terms of the cycle threshold
value (Ct), normalised for each sample using the Ct value
of 28S rRNA product for the same sample, as described
previously [26,27]. Final results are shown as corrected
ΔCt, using the normalised value.
Preparation of soluble APEC antigens and O78
lipopolysaccharide
LB broth (100 mL) containing 25 μg/mL nalidixic acid
was inoculated with APEC strain χ7122nalR and incubated
in a 250 mL Erlenmeyer flask overnight with shaking at
37 °C. Stationary phase bacteria were collected by centri-
fugation at 4000 × g for 30 min at 4 °C, washed 3 times,
re-suspended in 2 × 10 mL PBS and stored on ice. Bacter-
ial cells were disrupted by sonication (for a total of 2 min
with 20 s cooling intervals using a Sonicator XL ultra-
sonic processor (Heat Systems Inc., Farmingdale, NY, USA).
Cell debris was removed by centrifugation (1000 × g for
10 min) at 4 °C. The supernatant was further centrifuged
at 30 000 × g for 30 min at 4 °C to remove the insoluble
fraction. The supernatant containing soluble APEC anti-
gens was collected and kept on ice. The total protein con-
centration was determined by a colorimetric assay using
the bicinchoninic acid method (Pierce Biotechnology Inc.,
Rockford, IL, USA) before the soluble fraction was dispensed
into single-use aliquots and stored at −70 °C until required.
O78 lipopolysaccharide (LPS) was purified from 2 mL
of an overnight culture of strain χ7122nalR (OD600 = 1.2)
using a commercial LPS extraction kit (Chembio Ltd,
Hertfordshire, UK) as per the manufacturer’s protocol.
Approximately 30 μg of purified LPS was obtained from
2 mL culture and stored at 4 °C prior to use. Purity and
integrity of LPS was confirmed by silver-staining of ex-
tracts resolved by sodium dodecyl sulphate polyacryl-
amide gel electrophoresis (SDS-PAGE).
Table 1 Real-time quantitative RT-PCR probes and primers for turkey cytokines and primers for APEC genes used in
this study
Target Primer/Probe Sequence (5′- 3′) Species Reference
Cytokines
28S Probe (FAM)-AGGACCGCTACGGACCTCCACCA-(TAMRA) C, T [22]
Forward GGCGAAGCCAGAGGAAACT
Reverse GACGACCGATTTGCACGTC
IL-1β Probe (FAM)-CCACACTGCAGCTGGAGGAAGCC-(TAMRA) C, T [22]
Forward GCTCTACATGTCGTGTGTGATGAG
Reverse TGTCGATGTCCCGCATGA
CXCLi2 Probe (FAM)-TCTTTACCAGCGTCCTACCTTGCGACA-TAMRA C,T [23]
Forward GCCCTCCTCCTGGTTTCAG
Reverse TGGCACCGCAGCTCATT
IFN-γ Probe (FAM)-AAAGATATCATGGACCTGGCCAAGCTTCA-(TAMRA) T [23]
Forward AACCTTCCTGATGGCGTGAA
Reverse CTTGCGCTGGATTCTCAAGTC
IL-13 Probe (FAM)-TGCCAGCTGAGCACCGACAACG-(TAMRA) T [23]
Forward CCTGCACGGCCAGATGA
Reverse GGCAAGAAGTTCCGCAGGTA
IL-10 Probe (FAM)-CCTGAAGATGACAATGAAGCGCTGTCA-(TAMRA) T [23]
Forward CGACCTGGGCAACATGCT
Reverse CCTCTCGCAGGTGAAGAAGTG
TGF-β4 Probe (FAM)-ACCCAAAGGTTATATGGCCAACTTCTGCAT-(TAMRA) C, T [23]
Forward AGGATCTGCAGTGGAAGTGGAT
Reverse CCCCGGGTTGTGTTGGT
APEC genes
iss Forward ATCACATAGGATTCTGCCG - [24]
Reverse CAGCGGAGTATAGATGCCA
iucD Forward ACAAAAAGTTCTATCGCTTCC - [25]
Reverse CCTGATCCAGATGATGCTC
cvi/cvaC Forward TGGTAGAATGTGCCAGAGCAAG - [24]
Reverse GAGCTGTTTGTAGCGAAGCC
tsh Forward ACTATTCTCTGCAGGAAGTC - [24]
Reverse CTTCCGATGTTCTGAACGT
C = chicken, T = turkey.
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Single splenocyte suspensions were prepared essen-
tially as described [28]. Briefly, spleen tissue was passed
through a Falcon cell strainer (BD Biosciences, Oxford,
UK) in RPMI1640 medium (GibcoBRL, Paisley, UK) sup-
plemented with 100 U/mL penicillin, 1 μg/mL strepto-
mycin and 5% (v/v) foetal calf serum. The majority of
red blood cells were removed by gentle centrifugation at
35 × g for 10 min. The supernatant primarily comprised
lymphocytes, a few red blood cells and accessory cells
as assessed by light microscopy of a Giemsa-stained
smear. The cells were adjusted to a concentration of
5 × 106 cells/mL in RPMI1640 supplemented with 5%(v/v) foetal calf serum and dispensed into micro-titre
plates in 100 μL per well. For re-stimulation, 5 μg/mL of
APEC soluble antigen or 4 μg/mL of Concanavalin A
were added per well as required. When necessary, spleno-
cytes were stimulated with 0.3 μg of purified LPS ser-
ogroup O55:B5 (Sigma, St Louis, MO, USA). After 24 h
of incubation at 41 °C, 5% CO2, the cell suspensions
were pulsed with 1 μCi3H-thymidine (Amersham, Little
Chalfont, UK) per well. The plates were incubated for a
further 16 h at 41 °C before harvesting with a Tomtec
Mach IIIM cell harvester (Receptor Technologies, Banbury,
UK). Incorporation of 3H-thymidine was measured using a
1450 Microbeta Trilux Scintillation counter (Perkin-Elmer,
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minute (cpm).
Enzyme-linked immunosorbent assay (ELISA)
Nunc 96-well ELISA plates were coated with 1 μg of sol-
uble APEC antigen or 0.6 μg of purified O78 LPS in
100 μL of coating buffer (KPL Inc., Gaithersburg, MD,
USA) overnight at 4 °C. Excess antigen was removed by
washing the Plates 3 times in PBS supplemented with
0.05% (v/v) Tween-20 (PBS-T). The plates were blocked
with PBS-T containing 5% (w/v) skimmed milk (blocking
buffer) for 1 h at room temperature with gentle agitation
and then washed once in PBS-T. Pre-determined sample
dilutions of serum (1:640) or bile (1:2) in PBS-T plus 0.5%
(w/v) skimmed milk were added to antigen-coated wells
and incubated at room temperature for 1 h with gentle
agitation. Excess antibodies were removed by washing 3
times in PBS-T. Plates containing serum were incubated
with a 1:2000 dilution of goat anti-turkey IgY (H + L)
horse-radish peroxidise conjugate (KPL Inc., Gaithersburg,
Maryland, USA) whilst plates containing bile were incu-
bated with a 1:10 000 dilution of goat anti-chicken IgA
(Serotec, Oxford, UK) at room temperature for 1 h. After
removal of excess secondary antibodies, tetramethylbenzi-
dine substrate (TMB, Sigma) was added and the plates
incubated in the dark at room temperature for 10 min.
Colour formation was stopped with 2 M sulphuric acid.
The absorbance was read at 450 nm (OD450) with a back-
ground correction of 630 nm.
In vitro bactericidal activity of immune and non-immune
sera
To assess bactericidal activity of APEC-specific antibodies,
E. coli strains χ7122nalR and χ7145nalR (an isogenic Δrfb
mutant) were cultured in sera derived from challenged
and control birds obtained at day 42 as described [29].
Briefly, overnight broth cultures were sub-cultured in
fresh LB broth, grown to mid-logarithmic phase, har-
vested, washed and adjusted in PBS to approximately
108 CFU per mL. For each strain, 100 μL of bacterial
suspension was separately mixed with 900 μL of im-
mune serum, non-immune serum or LB broth (positive
control) and incubated statically at 37 °C. Bacterial counts
were determined by plating serial ten-fold dilutions of
20 μL sampled from each mixture at 0, 1, 2 and 3 h of in-
cubation. When required, complement was inactivated by
incubating sera at 56 °C for 1 h prior to the assays. The
data presented for each strain are the mean of three inde-
pendent assays performed in triplicate per serum sample.
Statistical analyses
Statistical analysis of data from splenocyte re-stimulation
and ELISA assays for infected and control groups was
carried out using a Mann–Whitney U-test [30]. For thecytokine analyses, a one-way analysis of variance (ANOVA)
was performed to detect differences between mean values,
which were then analysed further for significance with
Tukey’s test. Bacterial counts from tissues were analysed
using a Student’s t-test. Bacterial survival in sera was
analysed by an F-test, with the bacterial counts taken
as repeated measurements and the growth medium as a
covariant (Proc Mixed, Statistical Analysis System 1995,
SAS Institute, Cary, NC, USA). In all cases, P values ≤ 0.05
were considered significant.
Results
Development of a turkey model of sub-acute primary
APEC O78:H9 infection
Intra-airsac inoculation of two-week-old turkey poults
with 105 CFU of APEC O78:H9 strain χ7122nalR re-
sulted in mild clinical signs (ruffled feathers, hunched
posture and depression) which resolved within 24 h in
all the challenged birds. Such clinical signs were absent
in the control group that received sterile saline via the
same route. After 24 h, APEC-challenged birds remained
normal in appearance for the duration of the study. Five
birds were randomly sampled per group to determine
the level of bacterial colonisation, the degree of path-
ology and the induction of splenocyte responses. At
post-mortem examination, pathological lesions including
all or one of; airsacculitis, pericarditis, perihepatitis and
fibrin deposits on serosal surfaces were observed in all
APEC-infected birds killed at days 1 and 3 post-infection
(pi) (Table 2), but not in control birds. Enumeration of
tissue-associated APEC revealed ca. 107 CFU nalidixic acid-
resistant E. coli per gram of lung and liver tissues 1 day
after infection (Figure 1). The number of birds exhibiting
lesions decreased with time (Table 2) consistent with the
declining numbers of nalidixic acid- resistant E. coli recov-
ered from the tissues (Figure 1). All colonies examined
were shown to possess the O78 antigen and genes found
in χ7122nalR but not most avian faecal E. coli. No E. coli
were isolated from the organs of any bird in the control
group at any time. At day 14 pi, none of the APEC-
infected birds yielded bacteria from either the lung or liver
by direct plating or enrichment, implying that they had
cleared the infection. Minimal variance was detected in
bacterial numbers in the organs sampled or clinical signs,
reducing the likelihood of highly variable host responses.
Analysis of cytokine mRNA levels following primary APEC
O78:H9 infection
Very different patterns of cytokine mRNA expression
were seen in the lung and liver of APEC-infected birds.
In the lung (Figure 2), cytokine mRNA levels were sug-
gestive of a Th1 response. IL-1β mRNA levels were
up-regulated in challenged birds, compared to levels in
age-matched control birds, from days 1–14 pi, although
Table 2 The relationship between clinical signs, post-mortem lesions, recoveries of APEC strain χ7122nalR from lung
and liver and splenocyte proliferation in response to χ7122nalR soluble antigen in the first 14 dpi
Parameter Dpi
Day 1 Day 3 Day 5 Day 7 Day 14
Bird number Bird number Bird number Bird number Bird number
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Clinical signs1 + + + + + - - - - - - - - - - - - - - - - - - - -
Post-mortem lesions2 + + + + + + + + + + + + + - - + - - - - - - - - -
Log10CFU APEC
Lung 8.9 7.6 7.2 7.5 7.6 6.1 5.2 4.2 5.1 6.8 5.3 4.2 6.4 5.4 5.3 5.2 4.2 7.0 5.8 5.6 0 0 0 0 0
Liver 8.3 7.1 6.5 5.9 6.1 4.7 4.2 1.0* 1.0* 1.0* 4.2 1.0* 4.5 1.0* 0 3.2 3.3 1.0* 0 0 0 0 0 0 0
Splenocyte proliferation3 - - - - - - - - - - - - - - +a - - - +a +a +b +b +b +b +b
1Depression, ruffled feathers, hunched posture.
2Airsacculitis, pericarditis, perihepatitis, fibrin on serosal surfaces; + = presence any of the clinical or pathological signs; - = absence of any observable clinical or
pathological signs. None of these clinical signs or post-mortem lesions was seen in the control group of birds given sterile saline.
3Splenocyte proliferation, - = no response; +a = counts between 200–250 cpm; +b = counts ≥ 2000 cpm.
Bacterial recoveries from lung and liver are given as log10CFU. * = denotes a theoretical value of bacteria obtained after enrichment.
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14. Levels of mRNA for IFN-γ, the signature Th1 cytokine,
were up-regulated from days1-21 pi, but were statistically
significantly different only at day 5. A mixed pattern was
seen with the signature anti-inflammatory cytokines of a T
regulatory response, IL-10 and TGF-β4. IL-10 mRNA ex-
pression levels were up-regulated in challenged birds from
days 1–7 pi, statistically significantly so at day 5, whereas
mRNA expression levels of TGF-β4 were down-regulated
post-challenge throughout the experiment, with statisti-
cally significant differences at days 5, 21 and 28. In the
liver (Figure 3), cytokine mRNA expression levels were
suggestive of an anti-inflammatory response. In general,
mRNA expression levels of the pro-inflammatory innate-
induced cytokines IL-1β and CXCLi2 were down-regulated
following challenge (statistically significant from day 5–28Figure 1 Recoveries of nalidixic acid-resistant E. coli after
primary infection. Two-week-old turkey poults were given 105 CFU
of APEC O78:H9 strain χ7122nalR via the intra-airsac route. Five birds
were randomly selected, humanely killed and lung (open bars) and
liver (shaded bars) sampled for enumeration of bacteria at each
time-point. The data represent the mean log10CFU/g tissue ±
standard error (SE) of the mean.pi for IL-1β, and days 3, 5, 14 and 21 pi for CXCLi2). IFN-
γ mRNA expression levels were also down-regulated from
days 3–28 pi (statistically significant at days 14–28 pi). In
contrast, IL-13 mRNA expression levels were up-regulated
from day 5–28 pi, although none of the observed differ-
ences were statistically significant. The most obvious differ-
ences between challenged and control birds in the liver
were seen for the T regulatory cytokines. Both were up-
regulated post-challenge, with these differences being sta-
tistically significant for IL-10 throughout the experiment
and for TGF-β4 from day 3 pi for the remainder of the
experiment.
Primed birds are solidly protected against homologous
re-challenge
To evaluate if primary infection could protect turkey
poults against homologous re-infection, we inoculated
10 birds from the control and APEC-primed groups with
107 CFU of strain χ7122nalR on day 41 post-primary in-
oculation. At 24 h post-inoculation, 4/10 birds previ-
ously primed with APEC had ruffled feathers and brief
periods of anorexia (which lasted no more than 4 h) and
the remainder had no clinical signs, whilst the group that
was previously mock-infected exhibited clinical signs of
acute colibacillosis as defined above, as well as lesions typ-
ical of acute colibacillosis at post-mortem examination
(Table 2). Consistent with such signs and lesions, signifi-
cantly higher numbers of bacteria were recovered from
visceral organs of birds in the control group compared to
the APEC-primed group (Figure 4).
Proliferative responses of splenocytes to APEC antigens
after primary or mock infection
To evaluate whether primary infection induced cellular
immune responses specific to APEC antigens, we per-
formed ex vivo stimulation assays on splenocytes from
Figure 2 Levels of cytokine mRNA transcripts in the lung as measured by real-time qRT-PCR (Taqman). Results are expressed as corrected
ΔCt values ± SE, in the lungs of challenged (grey bars) and age-matched control (black bars) chickens. Five challenged and three control birds
were sampled per time-point. * = P≤ 0.05.
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http://www.veterinaryresearch.org/content/45/1/19infected and control birds at the same intervals when
bacterial counts were quantified in the lung and liver. In
APEC-infected birds, the mean proliferation of spleno-
cytes in response to Concanavalin A or soluble antigens
from χ7122nalR was low or absent on days 1, 3, 5 and 7
pi compared to their mock-infected counterparts, albeit
that variation in the response of splenocytes from con-
trol birds existed at these times (Figures 5A-B), possibly
arising from the out-bred nature of the birds. Statisti-
cally significant proliferative responses to χ7122nalR sol-
uble antigen were observed in infected birds relative to
the control group from day 14 pi onwards, coinciding
with a time-point when χ7122nalR was not recovered
from tissues. Such responses were absent in the control
group after re-challenge (day 42 pi) consistent with the
recovery of high numbers of χ7122nalR in tissues includ-
ing the spleen.
Primary APEC infection elicits antigen-specific IgY and IgA
responses
To determine if resistance to homologous re-challenge
could be associated with humoral responses, we measuredAPEC-specific serum IgY and bile IgA levels. Protected
birds had significantly higher levels of serum IgY anti-
bodies specific to both the χ7122nalR soluble antigen
and O78 LPS compared to the control group (Figures 6A
and B). Levels of APEC-specific IgY rose over time and
were significantly different from mock-infected birds from
7 days post-primary infection (Figure 6A). A significantly
higher level of IgA specific to χ7122nalR soluble antigen
was observed in bile samples from protected APEC-
primed birds compared to control birds at post-mortem
examination on day 42 (Figure 6C).
Serum from protected birds is bactericidal in vitro
To determine if immune serum was bactericidal, we
performed in vitro assays to quantify antibody-directed
complement-mediated killing. A log10-fold reduction in
the number of viable bacteria was obtained 2–3 h after in-
cubation with serum from birds infected with χ7122nalR
compared to that from control mock-infected birds
(Figure 7A). To determine if this was a consequence of
complement fixation, parallel assays were undertaken with
heat-inactivated sera. Net replication of strain χ7122nalR
Figure 3 Levels of cytokine mRNA transcripts in the liver as measured by real-time qRT-PCR (Taqman). Results expressed as corrected
ΔCt values ± SE, in the livers of challenged (grey bars) and age-matched control (black bars) chickens. Five challenged and three control birds
were sampled per time-point.* = P≤ 0.05.
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immune sera (Figure 7A). On the other hand, the net
growth of the isogenic Δrfb mutant was mildly impaired
by non-immune sera, but severely inhibited by immune
serum (Figure 7B).Figure 4 Recoveries of nalidixic acid-resistant E. coli from
internal organs after homologous re-challenge. APEC-primed
turkeys (n = 10) and their age-matched controls (n = 10) were
challenged with 107 CFU of APEC strain χ7122nalR via the intra-airsac
route and sampled after 24 h. The data represent the mean
log10CFU/g tissue ± standard error of the mean.* = P≤ 0.05;
** = P≤ 0.01; *** = P≤ 0.001.Discussion
To study the immunological basis of clearance of pri-
mary APEC infection we elected to infect two-week-old
turkey poults by the intra-airsac route, as previous studies
using turkeys older than three weeks of age failed to elicit
classical signs of colibacillosis and recoveries of APEC
from tissues were low [13,31]. Mitogenic responses of
turkey peripheral T cells develop rapidly after hatch and
reach adult levels by two weeks-of-age [32], therefore we
do not consider such birds to be immunologically imma-
ture. Whilst APEC may persist in the alimentary tract of
healthy birds [33], the respiratory tract is considered a sig-
nificant route of infection leading to systemic disease.
Aerosol, intra-tracheal, intranasal and intra-airsac incoula-
tion have been used to study APEC virulence factors,
antibody-mediated passive protection, genetic susceptibil-
ity, efficacy of antimicrobial compounds and to evaluate
candidate vaccines [10,11,15,34-36]. The merits and short-
comings of each of these respiratory infection models have
been reviewed [37]. Inoculation of APEC into the airsac of
healthy birds not only ensures that a standard dose is de-
livered at the site of natural infection [21], but circum-
vents upper respiratory mucosal defences that may reduce
the number of bacteria that eventually reach this site.
Figure 5 Splenocyte proliferation of turkeys at time intervals after
primary intra-airsac inoculation. Turkey poults were given 105 CFU of
APEC strain χ7122nalR and in uninfected controls were given sterile
saline via the same route. Re-stimulation assays were also performed
after challenge at day 42. Splenocyte suspensions were separately
stimulated with Concanavalin A (positive control; A) and strain
χ7122nalR soluble antigen (B). Five birds were sampled from each group
at each interval.* = P≤ 0.05; ** = P≤ 0.01; *** = P≤ 0.001.
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signs typical of acute colibacillosis, including ataxia, dys-
pnoea, rales and reduced response to stimulus, within
24 h of infection of naïve birds via the intra-airsac route
with ca. 107 CFU, and is therefore fully virulent [this study
and 21]. A close association between the reduction in
clinical/pathological signs and the declining numbers
of recovered APEC obtained in this study (Table 2) is
consistent with previous data in intra-airsac infection
models [10,11]. The model described here therefore pro-
vides an opportunity to study the nature and consequences
of adaptive immune responses following primary infection.
Cytokine responses elicited by APEC infection in the
lung were different from those in the liver. Though
inter-animal variation in responses of outbred birds lim-
ited conclusions to some extent, transcript levels for the
signature Th1 cytokine IFN-γ were elevated at the site of
primary infection on all days post-inoculation except day
28 pi, albeit only significantly so on day 5 pi. Induction
of a Th1 response, though not formally proven by these
data, would be consistent with the response expected for
an intracellular pathogen. Though not statistically sig-
nificant at all time-points sampled, transcripts encoding
the pro-inflammatory cytokines IL-1β and CXCLi2 wereup-regulated in the lung during the early phase of infec-
tion. In contrast, an anti-inflammatory response was
seen in the liver. Such strong responses are unusual in
poultry, let alone in the liver, especially when the bac-
teria were present in large numbers and clinical signs of
infection were present. Consistent with this strong anti-
inflammatory response, the regulatory cytokines IL-10
and TGF-β4 were up-regulated, being statistically signifi-
cant at most time-points post-infection. It remains to be
determined if these responses are driven by the host or
by the pathogen.
Adaptive responses were measured to examine their
association with protection against re-challenge. Though
it is evident that APEC was rapidly controlled at the site
of inoculation, it is unclear if the paucity of APEC in the
liver, spleen and kidney of primed birds reflects control
of bacteria that reached these organs, or absence of sys-
temic translocation of the bacteria from the lung. Control
of APEC at the site of inoculation could be partly attrib-
uted to elevated APEC-specific IgA levels, as detected in
the bile of protected birds. We determined IgA levels in
bile rather than the lung, owing to the possible interfer-
ence of APEC at the site of infection with ELISA tests
using lung washes, in accordance with published literature
[38,39]. Rising titres of IgY were also seen in serum from
day 7 onwards. It is possible that these humoral responses
induced by primary infection are associated with resist-
ance to re-challenge, as passive administration of hyper-
immune serum from birds immunised with inactivated
APEC O78 aided bacterial clearance from the blood and
opsono-phagocytosis in the liver [15,17,18]. Furthermore,
passively transferred egg-yolk antibodies conferred resist-
ance against APEC respiratory tract infection [40]. To
assess if such immune serum could be bactericidal
in vitro, we compared the net replication of APEC in
immune and non-immune sera. Consistent with pub-
lished literature [41-44], strain χ7122nalR was highly
resistant to non-immune serum, with the net replica-
tion over time resembling that when grown in LB broth
(Figure 7A), but decreasing in the presence of immune
serum. A similarity in the net replication of bacteria in
both heat-inactivated immune and non-immune sera sug-
gested that APEC-specific antibody was predominantly
enhancing complement-mediated lysis. The ability of im-
mune serum to impair the net growth of an isogenic Δrfb
mutant indicates that antibody-mediated killing in the
presence of complement is not strictly dependent on the
O-antigen.
Cell-mediated immunity was assessed by measuring sple-
nocyte responses to re-stimulation with strain χ7122nalR
soluble antigens. These responses were suppressed at sam-
pling points when APEC was recovered from the liver and
lung tissues (Figure 1). It is unclear whether the in-
hibition of mitogen-activated lymphocyte proliferation
Figure 6 Antibody levels in APEC- and mock-infected birds following primary infection and after homologous re-challenge. The levels
were measured by ELISA using different antigens; IgY levels against soluble χ7122nalR antigens (A), IgY levels against O78 LPS purified from
χ7122nalR (B) and IgA levels measured against soluble χ7122nalR antigens (C). At 0, 7, 14, 21, and 28 days post-primary infection, five birds per
group were sampled and ten birds per group were sampled after re-challenge (day 42). The data in panels B and C reflect levels at post-mortem
examination on day 42, one day after re-challenge. * = P≤ 0.05; ** = P≤ 0.01.
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http://www.veterinaryresearch.org/content/45/1/19was a consequence of bacterial interference. To ex-
clude the possibility that the lack of proliferative re-
sponse was due to loss of cell viability, we performed
a trypan blue dye exclusion test and confirmed sple-
nocyte viability after stimulation (data not shown).
Proliferative responses to the APEC antigens were seen in
mock-infected birds at three days pi and subsequent time-
points, suggesting non-specific stimulation or previous
exposure to similar antigens. To test if this non-specific
stimulation could have been caused by LPS (a non-
specific mitogen), we separately stimulated splenocytes
with purified LPS from E. coli serogoup O55:B5 and ob-
tained a similar pattern of responses (data not shown).
This suggested that the mock-infected birds could have
been exposed to LPS of environmental or commensal
E. coli. As earlier suggested, the lack of T cell responses in
APEC-infected birds early after infection could be a con-
sequence of bacterial interference. From day 14 onwards
proliferative responses of splenocytes from the infected
and control groups to soluble χ7122nalR antigens weresignificantly different from each other (Figure 5B), sug-
gesting the development of T cells specific to χ7122nalR
antigens. Such a pattern was not consistently evident
in the ConA-stimulated splenocytes at these intervals
(Figure 5A) since ConA is a non-specific mitogen. To
the best of our knowledge, we are the first to report
the induction of APEC-specific T cell responses after
primary infection of turkeys and the significant eleva-
tion of such responses relative to control birds may be
associated, though not formally correlated, with the resist-
ance of primed birds to re-infection. The extent to which
such APEC-specific T cells comprise effector or memory
populations requires further study.
In conclusion, we describe a model of sub-acute APEC
infection in turkeys in which a strain of a prevalent ser-
ogroup was rapidly cleared and poults solidly protected
against homologous re-challenge, in a manner associated
with the induction of both cell-mediated and humoral im-
munity. We recognise that further studies are required to
establish the role of the responses observed, for example
AB
Figure 7 Net replication of APEC strains in LB broth, immune
and non-immune turkey sera. Viable counts of χ7122nalR (A) and
its isogenic Δrfb mutant (B) were obtained over a 3 h incubation in
immune, heat-inactivated immune, non-immune, heat-inactivated
non-immune and LB broth. Bacterial counts were determined by
sampling 20 μL of culture and performing serial 10-fold dilutions be-
fore plating on Mac + Nal agar. The data represent the mean log10
CFU ± standard error from three independent assays performed
in triplicate.* = P ≤ 0.05.
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http://www.veterinaryresearch.org/content/45/1/19by passive transfer of antibody elicited by primary infec-
tion, bursectomy or adoptive transfer or depletion of cell
populations. Our study, nevertheless, provides a valuable
model to examine the nature and consequences of avian
responses to a key endemic pathogen, and provides evi-
dence of adaptive responses that could be exploited
in the design of strategies for control of colibacillosis
in poultry.
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